These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11689832)

  • 1. EU attempts to streamline biotech "vision".
    Hodgson J
    Nat Biotechnol; 2001 Nov; 19(11):1000. PubMed ID: 11689832
    [No Abstract]   [Full Text] [Related]  

  • 2. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 3. Ireland: delivering today and tomorrow.
    Med Device Technol; 2007 Oct; 18(6):43. PubMed ID: 18078182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing patent strategies: what will they mean for the industry?
    Mills AE; Tereskerz PM
    Nat Biotechnol; 2007 Aug; 25(8):867-8. PubMed ID: 17687359
    [No Abstract]   [Full Text] [Related]  

  • 5. BioPolis report paints fractured picture of EU biotech.
    Moran N
    Nat Biotechnol; 2007 Sep; 25(9):956-7. PubMed ID: 17846612
    [No Abstract]   [Full Text] [Related]  

  • 6. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU food agency circles round biotech.
    Hodgson J
    Nat Biotechnol; 1999 Oct; 17(10):945. PubMed ID: 10504684
    [No Abstract]   [Full Text] [Related]  

  • 8. SusChem industrial biotechnology--potentials and challenges in industrial biotech in Europe.
    Burel C
    ChemSusChem; 2008; 1(8-9):773-4. PubMed ID: 18686284
    [No Abstract]   [Full Text] [Related]  

  • 9. Tech transfer revs up.
    Lawrence S
    Nat Biotechnol; 2006 Jan; 24(1):13. PubMed ID: 16404380
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydrocarbons and renewable energy.
    Ringpfeil M
    Nat Biotechnol; 2004 Sep; 22(9):1077. PubMed ID: 15340466
    [No Abstract]   [Full Text] [Related]  

  • 11. EU enlargement brings biotech opportunities.
    Louët S
    Nat Biotechnol; 2004 May; 22(5):493-4. PubMed ID: 15122274
    [No Abstract]   [Full Text] [Related]  

  • 12. The emergence of Texas biotech.
    Richardson M
    Tex Med; 1994 Apr; 90(4):31-5. PubMed ID: 8009464
    [No Abstract]   [Full Text] [Related]  

  • 13. Scientists and societies. The Polish biotech gap.
    Gorlach S; Slabicki M
    Nature; 2004 Feb; 427(6977):870. PubMed ID: 14985771
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Biotech in Russia--Phoenix reborn from the ashes.
    Rabinovich M
    Biotechnol J; 2007 Jul; 2(7):771. PubMed ID: 17615595
    [No Abstract]   [Full Text] [Related]  

  • 15. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in the biotech literature.
    Lawrence S
    Nat Biotechnol; 2005 Apr; 23(4):408. PubMed ID: 15815656
    [No Abstract]   [Full Text] [Related]  

  • 17. Costa Rica's biotech project still on track for end of year.
    Corrales A
    Nature; 2008 May; 453(7195):586. PubMed ID: 18509417
    [No Abstract]   [Full Text] [Related]  

  • 18. Insights into US public biotech sector using patenting trends.
    Aggarwal S; Gupta V; Bagchi-Sen S
    Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White biotechnology: differences in US and EU approaches?
    Lorenz P; Zinke H
    Trends Biotechnol; 2005 Dec; 23(12):570-4. PubMed ID: 16253362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electoral campaign delays resolution of biotech issues.
    Fox JL
    Nat Biotechnol; 2004 Oct; 22(10):1193. PubMed ID: 15470439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.